Early research (Phase 1)Ended earlyNCT02519270What this trial is testingPhase 1, Dose-Escalation Study of IGN002 in NHL SubjectsWho this might be right forNon-Hodgkin Lymphoma Spectrum Pharmaceuticals, Inc 62
Testing effectiveness (Phase 2)Ended earlyNCT00265928What this trial is testingBortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's LymphomaWho this might be right forLymphoma University of Virginia 46
Not applicableStudy completedNCT02072967What this trial is testingRibomustin in the Second Line Therapy of Relapsed or Refractory Indolent B-cell Non-Hodgkin's LymphomaWho this might be right forLymphoma, Non-Hodgkin Astellas Pharma Europe B.V. 97
Early research (Phase 1)Active Not RecruitingNCT05753501What this trial is testingStudy to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell MalignanciesWho this might be right forHematologic Cancer AbbVie 135
Early research (Phase 1)Looking for participantsNCT06494371What this trial is testingLCAR-HL30 in Subjects With Relapsed/Refractory Hodgkin's Lymphoma and Anaplastic Large Cell LymphomaWho this might be right forHodgkin's LymphomaAnaplastic Large Cell Lymphoma Ruijin Hospital 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT03038672What this trial is testingNivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell LymphomasWho this might be right forALK-Positive Large B-Cell LymphomaDiffuse Large B-Cell Lymphoma Activated B-Cell TypeDiffuse Large B-Cell Lymphoma Associated With Chronic Inflammation+32 more National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)Study completedNCT00066599What this trial is testingVoriconazole in Preventing Fungal Infections in Children With Neutropenia After ChemotherapyWho this might be right forKidney CancerLeukemiaLymphoma+6 more National Cancer Institute (NCI)
Early research (Phase 1)Not Yet RecruitingNCT06314828What this trial is testingA Tolerability, Safety and Efficacy Study of RJMty19 in Subjects With Relapsed or Refractory B-NHLWho this might be right forB-cell Non-Hodgkin's Lymphoma Guangdong Ruishun Biotech Co., Ltd 30
Testing effectiveness (Phase 2)Study completedNCT03373071What this trial is testingAnti-CD19 CAR T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ ALL and NHLWho this might be right forCD19-ALLCD19-LNH Bambino Gesù Hospital and Research Institute 29
Testing effectiveness (Phase 2)Study completedNCT02086175What this trial is testingClinical Trial of Rituxan and B-Glucan PGG in Relapsed Indolent Non-Hodgkin LymphomaWho this might be right forRelapsed/Refractory Indolent B Cell Non-Hodgkin Lymphomas Dana-Farber Cancer Institute 25
Testing effectiveness (Phase 2)Temporarily pausedNCT07098364What this trial is testingST-067 in Combination With CD19-Directed CAR T-Cell Therapy (Liso-cel) in Relapsed/Refractory Large B-Cell LymphomaWho this might be right forRecurrent Diffuse Large B-Cell LymphomaRecurrent Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedRecurrent Grade 3b Follicular Lymphoma+9 more Fred Hutchinson Cancer Center 33
Testing effectiveness (Phase 2)WithdrawnNCT00310128What this trial is testingCombination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's LymphomaWho this might be right forAIDS-related LymphomaAdult Non-Hodgkin's LymphomaAnaplastic Large Cell Lymphoma AIDS Malignancy Consortium
Testing effectiveness (Phase 2)Study completedNCT00105001What this trial is testingTacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic CancerWho this might be right forMyelodysplastic/Myeloproliferative Neoplasm, UnclassifiablePreviously Treated Myelodysplastic SyndromeRefractory Chronic Lymphocytic Leukemia+113 more Fred Hutchinson Cancer Center 210
Early research (Phase 1)Study completedNCT05190068What this trial is testingHMPL-760 in Relapsed/Refractory B-Cell Non-Hodgkin's LymphomaWho this might be right forB-Cell Non-Hodgkin's Lymphoma Hutchmed 89
Not applicableNot Yet RecruitingNCT07713511What this trial is testingINfections in Patients Treated With CAR-TWho this might be right forRelapsed Multiple MyelomaRefractory Multiple MyelomaB-Cell Non-Hodgkin Lymphoma+2 more IRCCS Azienda Ospedaliero-Universitaria di Bologna 290
Early research (Phase 1)Looking for participantsNCT05798897What this trial is testingSafety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory LymphomaWho this might be right forNon-Hodgkin Lymphoma, AdultNon-Hodgkin Lymphoma, RefractoryNon-Hodgkin Lymphoma, Relapsed+4 more Marker Therapeutics, Inc. 79
Early research (Phase 1)Study completedNCT03029338What this trial is testingCD19 CAR T Cells in Patients With Relapsed or Refractory CD19 Positive B-cell LymphomaWho this might be right forLymphomas Non-Hodgkin's B-CellRelapse Institute of Hematology & Blood Diseases Hospital, China 20
Testing effectiveness (Phase 2)Study completedNCT00048555What this trial is testingSafety and Efficacy of IDEC-114 in Combination With Rituxan in the Treatment of Non-Hodgkin's LymphomaWho this might be right forNon-Hodgkin's Lymphoma Biogen 90
Early research (Phase 1)WithdrawnNCT07049432What this trial is testingN-803 Maintenance Therapy Post CAR T-cell Therapy in Patients With Relapsed or Refractory B-cell Non-Hodgkin LymphomasWho this might be right forB-cell Non Hodgkin Lymphoma University of Utah
Early research (Phase 1)Ended earlyNCT03379493What this trial is testingStudy of ET190L1 ARTEMIS™ T Cells in Relapsed and Refractory CD19+ Non-Hodgkin's LymphomaWho this might be right forLymphomas Non-Hodgkin's B-Cell Eureka Therapeutics Inc. 4